Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rhone-Poulenc reorganization to combine RPR and vaccines business: prelude to spin-off?.

Executive Summary

RHONE-POULENC PHARMACEUTICALS COMBINES RPR, PASTEUR-MERIEUX CONNAUGHT under the leadership of Group President Igor Landau, effective Jan. 1. Rhone-Poulenc SA is reorganizing its health and agro operations, the company said Nov. 18. Rhone-Poulenc Rorer will continue to be directed by Chairman Michel de Rosen and Pasteur Merieux Connaught will continue to be run by Chairman Jean-Jacques Bertrand. The vaccines business recently combined the Pasteur-Merieux and Connaught operations under one corporate rubric ("The Pink Sheet" Nov. 18, In Brief).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029230

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel